Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Astrocytoma (Phase 1)
Blast Crisis (Phase 1/Phase 2)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Colorectal Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 1)
Head and Neck Neoplasms (Phase 2)
Hepatitis D (Phase 2)
Hepatitis D, Chronic (Phase 2)
Leukemia (Phase 1/Phase 2)
Leukemia, Lymphoid (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Liver Diseases (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma (Phase 1)
Myelodysplastic Syndromes (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1/Phase 2)
Progeria (Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Sarcoma (Phase 1)
Stomach Neoplasms (Phase 1/Phase 2)
Supratentorial Neoplasms (Phase 1)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue